Catalyst Wire Dossier Catalyst Wire Dossier

KDF1901

KDF1901 · Kyungdong Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KDF1901, covering 2025-08-12 to 2025-08-12. Get the full timeline:

Most recent: Clinical Trial Update: A Multicenter, Randomized, Double-Blind Phase 3 Trial of KDF1901 in Patients With Essential Hypertension [Phase 3]

See pricing